Jonathan Kerr

Jonathan Ricardo Kerr, BSc, MBBCh, MD, PhD, FRCPath, is a British researcher who became interested in ME/CFS after studying the consequences of parovirus B19 infection and finding that some of those infected went on to develop CFS. Formerly of St. George’s University of London, he is presently working as an Associate professor in the School of Medicine and Health Sciences at Universidad del Rosario, Bogotá, Colombia.

Notable studies

 * 2016, Prevalencia de síntomas de fatiga crónica / encefalomielitis miálgica (SFC/EM) y su relación con factores ocupacionales en trabajadores en una empresa de vigilancia en Bogotá, Colombia
 * 2016, MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)

Talks & interviews

 * 2015, Spoonie radio episode 14 - Jonathan Kerr
 * 2014, Dr. Kerr, I presume?

Invest in ME International ME Conference

 * 2010, Speaker at the 5th [[Invest in ME International ME Conference] on Study of SNPs to determine subtype status in CFS patients] DVD available
 * 2009, Speaker at the 4th [[Invest in ME International ME Conference] on Severely-affected Sub Groups of ME/CFS] DVD available
 * 2008, Speaker at the 3rd [[Invest in ME International ME Conference] on Gene Expression in ME/CFS: a means of Subtyping] DVD available
 * 2007, at the 2nd [[Invest in ME International ME Conference] on Case Study - Biomedical research (A view of a biomedical research team, how it is funded, what it needs, how it could be improved, what the future research would look like)] DVD available
 * 2006, Speaker at the 1st [[Invest in ME International ME Conference] on Viral and Human Gene Expression, development of diagnostic test, news of clinical trials] DVD available

Online presence

 * Invest in ME - Jonathan Kerr
 * PubMed - Jonathan Kerr

Learn more

 * Jonathan Kerr